合計 50 件の最近のインサイダー取引記録が記録されています Blueprint Medicines Corporation (BPMC), 内訳は 18 件の買い および 32 件の売り. インサイダー買い総額は $78.81M インサイダー売り総額は $8.99M.
最近活動のある主要インサイダーには Borisy Alexis, Seely Lynn, Beckman Daniella. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — BPMC
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-18 |
Borisy Alexis |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
78,062 |
| 2025-06-18 |
Seely Lynn |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
17,156 |
| 2025-06-18 |
Beckman Daniella |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
14,744 |
| 2025-06-18 |
Goldberg Mark Alan |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
22,156 |
| 2025-06-18 |
Coats Lonnel |
Director |
RSU 付与（制限付株式） |
3,902 |
$12,812.00 |
$49.99M |
6,144 |
| 2025-06-18 |
Albers Jeffrey W. |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
150,532 |
| 2025-06-18 |
Dable Habib J |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-18 |
Tsai John |
Director |
RSU 付与（制限付株式） |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-03 |
Carter Percy H. |
Chief Scientific Officer |
情報に基づく売り |
2,418 |
$127.88 |
$309.21K |
54,206 |
| 2025-05-27 |
Albers Jeffrey W. |
Director |
オプション行使（売却） |
5,000 |
$36.05 |
$180.25K |
92,500 |
| 2025-05-19 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
57 |
$101.72 |
$5.8K |
64,718 |
| 2025-05-05 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
144 |
$103.56 |
$14.91K |
66,992 |
| 2025-05-05 |
Hurley Ariel |
Principal Accounting Officer |
オプション行使（売却） |
2,752 |
$54.13 |
$148.97K |
2,751 |
| 2025-04-01 |
Haviland Kate |
Chief Executive Officer |
情報に基づく売り |
100 |
$88.59 |
$8.86K |
165,929 |
| 2025-03-24 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
2,274 |
$95.02 |
$216.08K |
69,266 |
| 2025-03-12 |
Albers Jeffrey W. |
Director |
オプション行使（売却） |
7,500 |
$36.05 |
$270.38K |
97,500 |
| 2025-03-06 |
Hewes L. Becker |
Chief Medical Officer |
情報に基づく売り |
2,541 |
$87.98 |
$223.56K |
30,419 |
| 2025-03-05 |
Landsittel Michael |
Chief Financial Officer |
情報に基づく売り |
5,284 |
$88.80 |
$469.22K |
72,924 |
| 2025-03-05 |
Haviland Kate |
Chief Executive Officer |
情報に基づく売り |
16,151 |
$88.80 |
$1.43M |
168,427 |
| 2025-03-05 |
Mccain Tracey L |
EVP and Chief Legal Officer |
情報に基づく売り |
5,262 |
$88.80 |
$467.27K |
66,583 |
| 2025-03-05 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
6,495 |
$88.80 |
$576.76K |
71,540 |
| 2025-03-05 |
Hurley Ariel |
Principal Accounting Officer |
情報に基づく売り |
1,326 |
$88.80 |
$117.75K |
16,944 |
| 2025-03-05 |
Durso-bumpus Debra |
Chief People Officer |
情報に基づく売り |
5,157 |
$88.80 |
$457.94K |
49,606 |
| 2025-03-05 |
Namouni Fouad |
President, R & D |
情報に基づく売り |
6,489 |
$88.80 |
$576.22K |
75,781 |
| 2025-03-05 |
Hewes L. Becker |
Chief Medical Officer |
情報に基づく売り |
4,863 |
$88.80 |
$431.83K |
35,651 |
| 2025-03-05 |
Lee Philina |
Chief Commercial Officer |
情報に基づく売り |
3,733 |
$88.80 |
$331.49K |
41,996 |
| 2025-03-05 |
Carter Percy H. |
Chief Scientific Officer |
情報に基づく売り |
3,530 |
$88.80 |
$313.46K |
56,865 |
| 2025-03-05 |
Albers Jeffrey W. |
Director |
情報に基づく売り |
5,766 |
$88.80 |
$512.02K |
146,630 |
| 2025-03-03 |
Hurley Ariel |
Principal Accounting Officer |
情報に基づく売り |
1,075 |
$95.16 |
$102.3K |
18,270 |
| 2025-03-01 |
Landsittel Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Haviland Kate |
Chief Executive Officer |
RSU 付与（制限付株式） |
70,400 |
$96.57 |
$6.8M |
70,400 |
| 2025-03-01 |
Mccain Tracey L |
EVP and Chief Legal Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Rossi Christina |
Chief Operating Officer |
RSU 付与（制限付株式） |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hurley Ariel |
Principal Accounting Officer |
RSU 付与（制限付株式） |
7,007 |
$96.57 |
$676.67K |
7,007 |
| 2025-03-01 |
Durso-bumpus Debra |
Chief People Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Namouni Fouad |
President, R & D |
RSU 付与（制限付株式） |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hewes L. Becker |
Chief Medical Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Lee Philina |
Chief Commercial Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Carter Percy H. |
Chief Scientific Officer |
RSU 付与（制限付株式） |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-02-20 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
2,274 |
$95.14 |
$216.35K |
64,835 |
| 2025-01-21 |
Albers Jeffrey W. |
Director |
オプション行使（売却） |
10,000 |
$36.05 |
$360.5K |
105,000 |
| 2025-01-21 |
Haviland Kate |
Chief Executive Officer |
情報に基づく売り |
1,446 |
$110.24 |
$159.41K |
149,378 |
| 2025-01-21 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
121 |
$111.81 |
$13.53K |
67,109 |
| 2025-01-13 |
Albers Jeffrey W. |
Director |
オプション行使（売却） |
5,000 |
$36.05 |
$180.25K |
115,000 |
| 2025-01-13 |
Hurley Ariel |
Principal Accounting Officer |
オプション行使（売却） |
2,250 |
$36.05 |
$81.11K |
2,250 |
| 2024-12-19 |
Albers Jeffrey W. |
Director |
オプション行使（売却） |
15,000 |
$36.05 |
$540.75K |
120,000 |
| 2024-12-18 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
108 |
$96.50 |
$10.42K |
69,383 |
| 2024-12-12 |
Hurley Ariel |
Principal Accounting Officer |
オプション行使（売却） |
1,600 |
$15.01 |
$24.02K |
- |
| 2024-11-29 |
Haviland Kate |
Chief Executive Officer |
情報に基づく売り |
207 |
$97.76 |
$20.24K |
150,824 |
| 2024-11-27 |
Rossi Christina |
Chief Operating Officer |
情報に基づく売り |
2,274 |
$95.10 |
$216.26K |
71,657 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
